Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

This study has been completed.
Information provided by:
Roswell Park Cancer Institute Identifier:
First received: January 28, 2000
Last updated: March 3, 2011
Last verified: March 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2001
  Primary Completion Date: June 2000 (Final data collection date for primary outcome measure)